Is vaginal progesterone treatment associated with the development of gestational diabetes? A retrospective case–control study

PURPOSE: To determine the incidence of gestational diabetes mellitus (GDM) in pregnant women who received vaginal progesterone due to short cervical length or to prevent recurrent preterm birth. METHODS: In this retrospective study, we included 190 women with singleton pregnancies at risk for preter...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosta, Klara, Ott, Johannes, Kelemen, Fanni, Temsch, Wilhelm, Lahner, Tobias, Reischer, Theresa, Helmer, Hanns, Somogyi, Aniko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Maternal-Fetal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244685/
https://www.ncbi.nlm.nih.gov/pubmed/30225687
http://dx.doi.org/10.1007/s00404-018-4895-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244685/
https://www.ncbi.nlm.nih.gov/pubmed/30225687
http://dx.doi.org/10.1007/s00404-018-4895-1

Ejemplares similares